推进病毒氨酸的结构,功能和药理学领域:IUPHAR审查39
Kira Devantier1,2, Viktoria M S Kjær1, Stephen Griffin3,4
1Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
British journal of pharmacology
|September 3, 2024
概括
病毒素是病毒的关键目标,但开发抑制剂面临着障碍. 本综述概述了挑战,并提出了推进针对病毒的抗病毒药物的最佳实践.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 病毒素在病毒生命周期中起着至关重要的作用,使它们成为有吸引力的抗病毒点.
- 开发病毒抑制剂的当前挑战包括缺乏3D结构和功能表征的困难.
- 像阿曼塔丁这样的现有药物突出了针对病毒素的潜力,但也突出了其局限性.
研究的目的:
- 为了提供对病毒的结构和功能特征的全面概述.
- 识别和解决阻碍病毒抑制剂临床进展的挑战.
- 为病毒素鉴定,表征和药物开发提出最佳实践建议.
主要方法:
- 文献综述和对病毒素现有研究的综合.
- 对各种病毒蛋白的结构和功能数据的分析.
- 讨论抑制剂开发中的挑战和潜在的解决方案.
主要成果:
- 病毒蛋白表现出多样化的结构和功能特征,具有可塑的能量景观.
- 关键的挑战包括获得可靠的3D结构,功能性表征和验证抑制剂-病毒蛋白结合.
- 建议采用最佳实践来明确病毒素的识别和表征.
结论:
- 克服当前的挑战对于成功开发针对病毒的抗病毒药物至关重要.
- 采用标准化的方法将促进病毒抑制剂研究的进步.
- 针对病毒蛋白向药物的未来前景是有希望的,因为有了更好的理解和技术.
相关概念视频
Structure of Porins
2.9K
Mitochondria, chloroplasts, and gram-negative bacteria have transmembrane, beta-barrel proteins called porins to mediate the free diffusion of ions and metabolites across the membrane. Mitochondrial porin precursors contain conserved amino acid sequences called beta signals at their C-terminal. Beta signals have a motif of PoXGXXHyXHy (Po-Polar, X-Any amino acid, G-Glycine, Hy-LargeHydrophobic), which are crucial for precursor recognition to initiate precursor assembly. Beta-barrel...
2.9K
Pore Transport and Ion-Pair Transport
399
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
399
Aquaporins
4.8K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
4.8K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
ATP Driven Pumps III: V-type Pumps
3.6K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.6K
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679


